Boothbay Fund Management, LLC Annexon, Inc. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.33 - $6.79 $1.18 Million - $1.85 Million	-271,783 Reduced 72.42%	103,493 $507,000
Q1 2024 May 15, 2024	SELL	$4.03 - $7.81 $1.34 Million - $2.6 Million	-332,539 Reduced 46.98%	375,276 $2.69 Million
Q4 2023 Feb 14, 2024	BUY	$1.63 - $4.63 $1.15 Million - $3.28 Million	707,815 New	707,815 $3.21 Million
Q1 2023 May 15, 2023	BUY	$3.74 - $7.46 $3,107 - $6,199	831 Added 5.38%	16,274 $62,000
Q4 2022 Feb 14, 2023	BUY	$4.56 - $6.61 $70,420 - $102,078	15,443 New	15,443 $79,000

146

102M

178K

159K

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $244M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.